| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Dolutegravir |
| Brand | Tivicay® |
| Indication | In combination with other anti-retroviral medicinal products for the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age. |
| Assessment Process | |
| Rapid review commissioned | 10/02/2014 |
| Rapid review completed | 13/03/2014 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Not Recommended |